{"originalText": "，缘于2个月余前入院，诊断为直肠隆起型管状腺癌，于2014.01.16在我科行“腹腔镜上直肠癌根治术（DIXON）”。术后病理示（201401611），：(直肠)，：肠隆起型绒毛状-管状腺癌II级，侵犯脉管组织，脉管内见癌栓，侵及深肌层（&GT;1/2肌层），手术标本双切端、环周切缘及另送(下切端)、(上切端)均未见癌浸润。找到肠周淋巴结2/18个，见癌转移。另送(肠系膜上动脉根部)镜上为脂肪、脉管及纤维结缔组织。，免疫组化结果：KI67（80%阳性），P53（+++），P170（++），GSTπ（个别细胞阳性），EGFR（-），5-FU（-），MLH1（+++），MSH6（个别细胞阳性），MGMT（++）。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。并于2014.02.16开始予“奥沙利铂150MGIVGTTD1+希罗达1000MGPOBIDD2-15”方案行术后第1周期化疗，患者耐受良好，此次为第2次化疗再次入院。出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 23}, {"label_type": "手术", "overlap": 0, "start_pos": 40, "end_pos": 57}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 98}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 268}, {"end_pos": 355, "label_type": "药物", "overlap": 0, "start_pos": 351}, {"end_pos": 371, "label_type": "药物", "overlap": 0, "start_pos": 368}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}]}
